TrialNeuro-oncology2024

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Jacoline E C Bromberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.